Pathway to Prevention study of the development of type 1 diabetes

25 Nov Pathway to Prevention study of the development of type 1 diabetes

TrialNet’s Pathway to Prevention studies the development of type 1 diabetes, and screens relatives of people with type 1 diabetes for their risk of developing the disease. Relatives of people with type 1 diabetes have about a 3 to 4 percent chance of being positive for the antibodies associated with diabetes. The Natural History Study is conducted in two parts:

– Screening
– Monitoring

This is the screening part of the study, in which a simple blood test is done to screen for the presence of diabetes-related antibodies.

If antibodies are confirmed to be present, participants will be invited to join the monitoring part of the study and have additional testing. People who are found to be at moderate to high risk of developing type 1 diabetes may be eligible to participate in a prevention trial.

TrialNet is an international network dedicated to the study, prevention and early treatment of type 1 diabetes. TrialNet sites are located throughout the United States, Canada, Finland, United Kingdom, Italy, Australia, and New Zealand.

Participant Eligibility

You qualify for free risk screening if you:

-Are between the ages of 2 and 45 years and have a parent, brother/sister, or child with T1D
-Are between the ages of 2 and 20 years and have an aunt/uncle, cousin, grandparent, niece/nephew, or half-brother/sister with T1D
-Have not been diagnosed with diabetes

OR

-Are between the ages of 2 and 45 years and have tested positive for at least one T1D related autoantibody outside of TrialNet
-Have not been diagnosed with diabetes

Contact

the BRI Outreach Team
(800) 888-4187

Interested?

Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.

I am interested in this research study.